Cereulide-Tainted Infant Milk Quietly Removed in EU

An investigation by a consortium of European public broadcasters — including RTBF (Belgium), Radio France, and RTS (Switzerland) — has revealed that infant milk formulas contaminated with the bacterial toxin cereulide were discreetly removed from supermarket and pharmacy shelves in Germany and Austria before official public recalls were issued. The quiet removal, which began in late December 2025 and continued into January 2026, has raised serious questions about transparency in food safety protocols and the adequacy of European recall regulations.

The Contamination Crisis

The contamination originated from arachidonic acid (ARA) oil, an additive used to replicate fats found in breast milk, supplied by the Chinese company Cabio Biotech, based in Wuhan. Nestlé first detected cereulide toxin at very low levels in infant formula produced at its Nunspeet plant in the Netherlands in late November 2025, as Le Monde first reported. On December 24, Nestlé confirmed that the contamination source was the ARA oil from Cabio Biotech, with samples showing concentrations of 0.7 and 0.5 micrograms per kilogram of powder.

The affected products — manufactured by Nestlé under the BEBA and Alfamino brands, and by Danone under the Aptamil brand — have since been linked to what has become the largest infant formula recall in history, affecting 99 countries and territories across six WHO regions. As of February 25, 2026, at least 144 suspected and confirmed cases had been reported across 10 countries, with Belgium recording the only laboratory-confirmed cases — eight in total.

The Silent Removal

Between December 24, 2025, and January 5, 2026, Nestlé, Danone, and Austrian and German health authorities removed affected products from store shelves without any public notification. The official public recall for Nestlé products was not published until January 5 — 12 days after the contamination was confirmed. Danone’s public recall came even later, on January 30, with silent removal beginning on January 24.

According to the German Ministry of Agriculture in Hessen, where Nestlé Deutschland is headquartered: “The public recall of Nestlé products took place on January 5, 2026. Previously, from December 24, 2025, products had already been withdrawn from sale as part of a discreet recall.” Regarding Danone, the ministry stated: “The public recall of Danone products took place on January 30, 2026. According to information provided by the regional contact point, products were already withdrawn from sale from January 24, 2026, as part of a discreet withdrawal.”

The Regulatory Distinction

Under EU regulations, there is a critical distinction between a “withdrawal” and a “recall.” As explained by the French Ministry of Economy, a withdrawal applies when a product is deemed “unsafe” but has not yet reached consumers, while a recall is required when products have already been sold to consumers and public communication is mandatory.

The Austrian Ministry of Health justified the quiet removal by stating that while the “samples tested were deemed unfit for human consumption” and therefore “unsafe” under EU Regulation No. 178/2002, the products were not deemed “harmful to health,” meaning “no public recall or media communication was required at this stage.”

Critics argue that this distinction is dangerously subtle when applied to products that had already been on the market since April 2025 and had been purchased by consumers — particularly the most vulnerable population, infants.

Industry and Regulatory Response

Nestlé defended its approach, stating in an email to the RTBF consortium: “Between December 23 and January 5, Nestlé carried out a very large number of checks (more than 400 samples) covering all batches of ARA oil supplied and the associated mixtures, as well as exhaustive traceability work, in order to precisely identify the products concerned.” The company argued that acting without consolidated information “would have led to an incomplete or erroneous recall,” and that since infant formulas are essential products, it was “imperative to strictly target recalls to the only batches concerned.”

The European Commission declined to comment on what it called “hypothetical scenarios,” stating that it is up to member states to confirm whether silent recalls occurred. The Commission has indicated it will conduct a post-event review, though no date has been set.

A Regulatory Gap Exposed

The crisis exposed a significant gap in EU food safety regulation: prior to February 2026, there was no European regulatory threshold for cereulide in food. Mary Gilsenan, Department Director at the European Food Safety Authority (EFSA), explained during a March 24 hearing at the European Parliament: “There was no European threshold, since this is a toxin (naturally present in the environment), so it had no reason to be there” — especially in milk intended for infants.

On February 2, 2026, in direct response to the crisis, EFSA established the first-ever acute reference dose (ARfD) for cereulide in infant formula: 0.014 micrograms per kilogram of body weight for infants. The rapid establishment of this threshold, however, raises questions about why no limit existed beforehand and whether the precautionary principle should have been applied more rigorously.

Legal and Political Fallout

In France, five criminal investigations were opened on January 30, 2026, for “endangering the lives of others.” Two infant deaths were investigated in connection with the contamination; cereulide was ruled out in two cases, with one still under investigation. The French parliamentary “flash mission,” led by deputy Mathilde Hignet, began work on March 24 to evaluate the responsibility of multinationals and the state’s strategy.

Global Supply Chain Vulnerability

The fact that contamination from a single ingredient supplier in Wuhan, China, affected 99 countries highlights the vulnerability of concentrated global supply chains for critical infant nutrition ingredients. The World Health Organization, which published a Disease Outbreak News report on March 13 assessing the overall public health risk as “Moderate,” noted that the full root cause analysis from Cabio Biotech had not yet been provided as of that date.

What’s Next

As the European Commission’s post-event review and the French parliamentary mission continue, this crisis may catalyze significant reforms in food safety regulation, supply chain oversight, and recall transparency protocols. The central question remains: how can the essential need for precise, targeted recalls be balanced with the fundamental right of consumers — especially parents of infants — to know about potential health risks in a timely manner?

For Belgian consumers, the implications are particularly acute. Belgium is the only country with laboratory-confirmed cases of cereulide poisoning, and the products were distributed across European borders. As Yvan Verougstraete, the Belgian MEP who initiated the March 24 parliamentary hearing, noted, the case exposes a system where regulatory gaps and ambiguous definitions can leave the most vulnerable consumers unprotected.